Trials / Terminated
TerminatedNCT00743470
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
A Comparison of the Bioavailability of Rifabutin With and Without Lopinavir/Ritonavir in Healthy Adult Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lopinavir/ritonavir | lopinavir/ritonavir tablet; see arm for intervention description |
| DRUG | rifabutin | rifabutin capsule; see arms for intervention description |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2008-10-01
- First posted
- 2008-08-28
- Last updated
- 2010-11-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00743470. Inclusion in this directory is not an endorsement.